IFN-gamma as an active substance for inhibiting and preventing d

Details IFN-gamma as an active substance for inhibiting and preventing d IFN-gamma as an active substance for inhibiting and preventing d

1986-05-30

1990-05-01

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

424 854, 530351, A61K 4502, C07K 1526

Patent

active

049216970

ABSTRACT:
This invention relates to methods for preventing and treating bone diseases caused by bone loss comprising administering to a patient a pharmaceutical composition with IFN-.gamma. as the active substance.

REFERENCES:
Kayander et al., The Lancet, vol. I, pp. 984-985, 1979.
Butler et al., The Lancet, vol. II, pp. 278-279, 1984.
Takahashi et al., J. Immunol., vol. 137, pp. 3544-3549, 1986.
Peterlik et al., FEBS Lett., 185:287-290 (1985).
Gowen, M., J. Immunol., 136:2478-2481 (1986).
Stephenson, M. L. et al., FEBS Lett., 180:43-50 (1985).
Jilka, R. L. et al., Biochem. Biophys. Res. Comm., 120:553-558 (1984).
Nilsson, O. S. et al., J. Interferon Res., 4:135-140 (1984).

Affiliated with

Also associated with

Rating

IFN-gamma as an active substance for inhibiting and preventing d does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with IFN-gamma as an active substance for inhibiting and preventing d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IFN-gamma as an active substance for inhibiting and preventing d will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-828535